Root Financial Partners’s Akero Therapeutics AKRO Stock Holding History

Root Financial Partners’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-31	Closed	-$1.47K	–	2437
2025 Q3	$1.47K	Buy	+31	New	+$1.5K	﹤0.01%	2003

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Root Financial Partners's AKRO Position: Q4 2025 in Review

Root Financial Partners sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 31 shares — an estimated $1.47K sold.

Root Financial Partners first reported a position in AKRO in Q3 2025 and held it in 1 quarter. The position peaked at $1.47K in Q3 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

Root Financial Partners reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
Root Financial Partners sold 31 Akero Therapeutics shares in Q4 2025, an estimated $1.47K.
Root Financial Partners first reported a position in Akero Therapeutics in Q3 2025 and held it in 1 quarter.
Root Financial Partners's Akero Therapeutics position peaked at $1.47K in Q3 2025.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Root Financial Partners's 13F filing for Q4 2025, filed 10 Feb 2026.